Location History:
- Bethesda, MD (US) (2021)
- Rockville, MD (US) (2018 - 2024)
Company Filing History:
4 out of 3,539 
1 out of 15 
1 out of 56 
Years Active: 2018-2024
Title: Innovations of Lei Chen in Respiratory Syncytial Virus Research
Introduction
Lei Chen is a prominent inventor based in Rockville, MD, who has made significant contributions to the field of virology, particularly in the study of Respiratory Syncytial Virus (RSV). With a total of four patents to his name, Chen's work focuses on developing innovative methods for treating and preventing RSV infections.
Latest Patents
Among his latest patents, Chen has disclosed groundbreaking work on prefusion RSV F proteins. These patents detail the development of RSV antigens, including a recombinant RSV F protein that is stabilized in a prefusion conformation. The patents also cover nucleic acids encoding these antigens and methods for producing them. Furthermore, Chen's work includes methods for generating an immune response in subjects, which can be utilized for treating or preventing RSV infections by administering a therapeutically effective amount of the antigen.
Career Highlights
Chen has had a distinguished career, working with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and The Pirbright Institute. His research has been pivotal in advancing our understanding of RSV and developing potential therapeutic strategies.
Collaborations
Throughout his career, Chen has collaborated with notable colleagues, including Baoshan Zhang and Barney S. Graham. These partnerships have further enriched his research and contributed to the scientific community's knowledge of RSV.
Conclusion
In summary, Lei Chen's innovative work in the field of RSV research has led to significant advancements in the development of vaccines and treatments. His contributions continue to impact the fight against respiratory infections, showcasing the importance of innovation in medical science.